Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Heat Shock Protein Inhibitors
>>
Phase 1
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
zelavespib intravenous
(PU-H71 IV) / Samus Therap
Jeselhy
(pimitespib) / Otsuka
XL888
/ Exelixis, Merck (MSD)
IPI 493
/ Innate
JIN-001
/ J Ints Bio
PAT-SM6
/ Patrys
CSL889 hemopexin
/ CSL Behring
CXA-10 IV
/ Complexa
DS-2248
/ Daiichi Sankyo
LAM 003
/ OrphAI Therap
TQB3474
/ Sino Biopharm
gamitrinib
/ Fox Chase Cancer Center, The Wistar Institute
recombinant human Hsp110-gp100 chaperone complex vaccine
/ National Cancer Institute, Roswell Park Comprehensive Cancer Center
zelavespib oral
(PU-H71 oral) / Samus Therap